ReviewDrug design, development and therapy2026

Development Trends of Janus Kinase Inhibitors (JAKi) Over Three Decades: From Common to Rare Diseases.

Rui Dai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.